| HCM (n=51) | Control (n=25) | p value |
---|---|---|---|
Age, y | 48 ± 14 | 48 ± 17 | 0.8 |
Males, n (%) | 39 (76%) | 18 (72%) | 0.7 |
Body mass index, kg/m2 | 27.5 ± 4.9 | 24.1 ± 2.7 | <0.001 |
Family history of HCM, n (%) | 17 (33%) | - | Â |
Symptoms, n (%) | Â | Â | Â |
Chest pain | 16 (31%) | - | Â |
Dyspnoea | 28 (55%) | - | Â |
NYHA class I or II | 51 (100%) | - | Â |
Presyncope | 18 (35%) | - | Â |
Syncope | 6 (12%) | - | Â |
Medications, n (%) | Â | Â | Â |
Beta-blocker | 29 (57%) | - | Â |
Calcium channel blocker | 10 (20%) | - | Â |
Resting heart rate, beats/min | 60 ± 10 | 62 ± 9 | 0.6 |
Systolic blood pressure, mm Hg | 129 ± 16 | 133 ± 18 | 0.4 |
Hematocrit | 0.43 ± 0.04 | 0.42 ± 0.03 | 0.3 |
eGFR, ml/min/1.73 m2 | 81 ± 12 | 86 ± 8 | 0.14 |